However, Ottewell et al. found that recombinant OPG markedly counteracts growth of dormant MDA-MB-231 cells at the skeletal level in a murine model of disseminated breast cancer cells, thus preventing development of bone metastases [122]. This evidence concerns the gene TNFRSF11B and breast cancer.